Oncoinvent ASA (KLDVK) — Financial Flexibility Index
Oncoinvent ASA (KLDVK) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of Nkr5.76 Million (operating CF Nkr3.64 Million minus capex Nkr2.12 Million) represents 0% of total liabilities (Nkr230.30 Million). Check how aggressively does Oncoinvent ASA reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncoinvent ASA Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Oncoinvent ASA across 5 annual periods. For the full cash flow conversion analysis, see Oncoinvent ASA (KLDVK) cash flow conversion.
Annual Financial Flexibility Index for Oncoinvent ASA (2021–2025)
Year-by-year free cash flow to debt coverage for Oncoinvent ASA. Explore cash flow to debt ratio of Oncoinvent ASA to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.04x | Nkr-8.47 Million | Nkr-23.24 Million | Nkr230.30 Million | ▼ -187.0% |
| 2024 | 0.04x | Nkr9.07 Million | Nkr-14.84 Million | Nkr214.71 Million | ▲ +129.2% |
| 2023 | -0.14x | Nkr-20.79 Million | Nkr-40.23 Million | Nkr143.77 Million | ▼ -238.3% |
| 2022 | 0.10x | Nkr12.50 Million | Nkr373.06K | Nkr119.51 Million | ▼ -80.0% |
| 2021 | 0.52x | Nkr31.01 Million | Nkr130.66K | Nkr59.25 Million | — |